Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when TTI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: TTI TETRA TECHNOLOGIES INC 8-K

TETRA launches $100M equity offering to fund Arkansas bromine project with $220M capex ahead

Filed June 2, 2026 · Period ending June 2, 2026 · ~1 min read

5 key changes 4 high relevance 2 sections

Key Changes

  • high

    TETRA intends to raise $100M through an underwritten public offering of common stock (plus up to $15M over-allotment option), with proceeds earmarked for general corporate purposes including construction of the Arkansas Bromine Project.

    Item 7.01 — Regulation FD Disclosure verify on EDGAR →
  • high

    Board approved final investment decision for Arkansas Bromine Project on May 28, 2026, subject to securing necessary financing; project targets 75M lbs annual elemental bromine capacity by early 2028.

    Item 8.01 — Other Events verify on EDGAR →
  • high

    Approximately $220M in remaining capex required over next two years for Arkansas project, to be funded through combination of offering proceeds, cash from operations, credit facility borrowings, and other financing sources.

    Item 8.01 — Other Events verify on EDGAR →
  • high

    TETRA finalized joint venture with Magrathea Metals to develop domestic magnesium metal production for defense, aerospace, and advanced manufacturing markets, leveraging Magrathea's electrolytic technology partially underwritten by U.S. Department of War.

    Item 8.01 — Other Events verify on EDGAR →
  • medium

    Company disclosed execution risks for Arkansas project including potential cost overruns, schedule delays, supply chain disruptions, contractor performance issues, labor constraints, and regulatory delays.

    Item 8.01 — Other Events verify on EDGAR →

Summary

TETRA Technologies announced a $100 million public equity offering to help fund its Arkansas Bromine Project, which received final board approval on May 28, 2026, contingent on securing financing. The company has invested approximately $49 million in the project through March 2026 and faces approximately $220 million in remaining capital expenditures over the next two years.

The project targets 75 million pounds of annual elemental bromine capacity by early 2028, with Phase 2 mechanical completion targeted by end of 2026 and Phase 3 by end of 2027. The offering proceeds will supplement cash from operations, credit facility borrowings, and other financing sources to complete construction.

The filing also disclosed a finalized joint venture with Magrathea Metals to develop domestic magnesium metal production for defense and aerospace markets, combining TETRA's processing expertise with Magrathea's electrolytic technology that has received partial U.S. Department of War underwriting. This represents a strategic expansion into critical minerals beyond bromine. The company acknowledged execution risks inherent in large-scale construction projects, including potential cost overruns, schedule delays, and supply chain disruptions. Retail holders should monitor project milestones and financing execution as TETRA commits substantial capital to this multi-year buildout.

Section-by-Section Diff

Event · Item 8.01 — Other Events

~1,200 words

TETRA disclosed operational updates on its Arkansas Bromine Project, including a final investment decision, $220M remaining capex, and new risk factors.

2 Added
Added Arkansas Bromine Project timeline and capacity high

Added in current filing · verify on EDGAR →

Phase 2 is underway and will include major infrastructure and equipment supporting the processing plant with mechanical completion targeted by the end of 2026. Phase 3 is expected to be completed at the end of 2027, and the plant is expected to begin operation in early 2028 and will have the installed capacity to process up to 75 million pounds of elemental bromine per year.

The project is progressing through three phases: Phase 2 targets mechanical completion by end of 2026, Phase 3 by end of 2027, with plant operations beginning in early 2028. The facility will have installed capacity to process up to 75 million pounds of elemental bromine annually, representing a significant new production capability.

Added Arkansas Bromine Project execution risks medium

Added in current filing · verify on EDGAR →

Construction projects of this scale carry inherent execution risks, including the potential for cost overruns, schedule delays, supply chain disruptions, contractor performance issues, labor availability constraints, regulatory or permitting delays, environmental matters, and other factors outside of our control.

The company disclosed new risk factors acknowledging that the Arkansas Bromine Project faces execution risks including cost overruns, schedule delays, supply chain disruptions, contractor performance issues, labor constraints, regulatory delays, and environmental matters. The company also noted that if other working interest owners do not fund their share of upstream costs, capital expenditures may increase beyond current estimates. These risks could materially affect the project's completion timeline, cost, and ultimate performance.

Event · Exhibit 99.1

2 Added
Added Use of proceeds medium

Added in current filing · view on EDGAR →

The Company intends to use the net proceeds it receives from the offering for general corporate purposes, including funding a portion of the construction costs of its Arkansas bromine project.

The net proceeds from the offering will be used for general corporate purposes, with a specific allocation toward funding construction costs of the company's Arkansas bromine project. This indicates capital deployment toward expanding the company's critical minerals business segment.

Show 1 minor / wording change
Added Over-allotment option low

Added in current filing · view on EDGAR →

The Company expects to grant the underwriters a 30-day option to purchase up to an additional $15 million of shares of Common Stock solely to cover any over-allotments at the public offering price, less the underwriting discounts and commissions.

The underwriters have been granted a standard greenshoe option to purchase up to $15 million of additional shares within 30 days to cover over-allotments. If fully exercised, the total offering size would reach $115 million.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 12, 2026 · How we verify